- Exchange: OTC BB
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Drug Delivery Systems
Snapshot for Aradigm Corp (ARDM)
| Open: | 0.0910 | Day's Range: | 0.0910 - 0.1040 | Volume: | 61,000 |
|---|---|---|---|---|---|
| Previous Close: | 0.0910 | 52wk Range: | 0.0910 - 0.1800 | 1-Yr Rtn: | -28.57% |
Key Statistics for ARDM
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | - |
| Est. EPS (USD) (12/2013) | -0.0400 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 25.17 |
| Shares Outstanding (M) | 251.69 |
| 30 Day Average Volume | 47,347 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/09/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ARDM
Company Profile & Key Executives for ARDM
Aradigm Corporation develops novel pulmonary drug delivery systems. The Company's systems are designed to enhance the delivery and effectiveness of a number of existing and development stage drugs and reduce the need for injectable drug therapy. Aradigm's principal product development programs are based on its AERx pulmonary drug delivery system.
| Igor GondaPresident/CEO | Nancy E PecotaVP:Finance/CFO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ARDM News
-
Industry News
No stories found
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page